Evidence map›Paper›PMID 35498053›Full record

ArticleClinical infection in practice2022

Post-acute coronavirus disease 2019 (COVID 19) syndrome:

Silvia Roda, Alessandra Ricciardi, Angela Maria Di Matteo, Marco Zecca, Patrizia Morbini, Marco Vecchia, Teresa Chiara Pieri, Paola Giordani, Angelo Tavano, Raffaele Bruno

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical infection in practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Post-COVID-19 cholangiopathy: Systematic review.World journal of methodology · 2023
    Article
  5. Post-COVID-19 Cholangiopathy: A Systematic Review.Journal of clinical and experimental hepatology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Silvia RodaDepartment of Clinical, Surgical, Diagnostic and Pediatric sciences, University of Pavia, Italy.
Alessandra RicciardiDepartment of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Angela Maria Di MatteoDepartment of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Marco ZeccaDepartment of Pediatric Hematology-Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Patrizia MorbiniDepartment of Pathology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Marco VecchiaDepartment of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Teresa Chiara PieriDepartment of Clinical, Surgical, Diagnostic and Pediatric sciences, University of Pavia, Italy.
Paola GiordaniDepartment of Clinical, Surgical, Diagnostic and Pediatric sciences, University of Pavia, Italy.
Angelo TavanoDepartment of Clinical, Surgical, Diagnostic and Pediatric sciences, University of Pavia, Italy.
Raffaele BrunoDepartment of Clinical, Surgical, Diagnostic and Pediatric sciences, University of Pavia, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITPoliclinico San Matteo Fondazione · ITUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sars-CoV2 can cause severe pneumonia and acute respiratory distress syndrome (ARDS). In COVID-19-associated respiratory failure, lung transplantation might be an option (Bharat A). Case report: A previously healthy 63-year-old man with a nasopharyngeal swab positive for SarsCoV2 and radiological evidence of interstitial lung consolidations developed acute respiratory distress that required intubation and veno-venous extracorporeal membrane oxygenation support (VV ECMO). Because of no recovery of his lung function, he underwent a bilateral lung transplant. ICU stay was complicated by several episodes of bacterial superinfections and an increase of liver function tests (LFTs). Afterward, he faced a progressive clinical worsening associated to severe anemia, further rise of indices of cholestasis, hypertriglyceridemia and hyperferritinemia. Bone marrow smear showed a picture compatible with haemophagocytic lymphohistocytosis (HLH) and first and second line therapy were started. In addition, a transjugular hepatic biopsy was performed with histopathological evidence of portal and periportal fibrosis, compatible with Covid 19-related cholangiopathy. During the hospital stay, he developed several MDR opportunistic infections. The patient died few months later from multiorgan failure secondary to septic shock. A post-mortem confirmed a diagnosis of cholangiopathy, and medullary Conclusion: Post Covid19 syndrome is a clinical entity that includes novel and old sequelae following recovery from Sars-CoV2 infections. Early identification of these diseases is crucial for adequate management and might influence the long term prognosis of these patients.

Indexed as

Haemophagocytic lymphohistocytosisPost COVID-19 CholangiopathyPost Covid19 syndromeSars-CoV2

Identifiers

PMID35498053
PMCPMC9040417
OpenAlexW4224529698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.